Stock Market Reviews

MASI (Masimo Corporation) News

Get the latest news, insights, and market updates on MASI (Masimo Corporation). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Warner Bros. reopens Paramount talks, Tripadvisor to revamp board
  Morning Brief host Julie Hyman takes a look at some of Tuesday morning's trending tickers and stories. Warner Bros. Discovery (WBD) is set to reopen acquisition discussions with Paramount (PSKY), potentially reigniting another bidding war with Netflix (NFLX). Tripadvisor's (TRIP) board will reportedly be overhauled by activist investor Starboard (SVACW), according to the Wall Street Journal. Medical-device maker Masimo (MASI) will reportedly be acquired by life sciences company Danaher (DHR) for $9.9 billion, according to the Financial Times. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
  Feb 17, 2026 - $MASI
• Top Midday Stories: Warner Bros. to Seek 'Best and Final' Offer From Paramount; Danaher to Acquire Masimo for $9.9 Billion
  Wall Street's major market averages were mixed in late-morning trading Tuesday on the first trading
  Feb 17, 2026 - $MASI
• Masimo to be Acquired by Danaher for $180.00 Per Share
  IRVINE, Calif., February 17, 2026--Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) ("Danaher") will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the "Transaction").
  Feb 17, 2026 - $MASI
• Danaher closes in on nearly $10bn deal for medical device maker Masimo
  US life sciences manufacturer Danaher is closing in on a nearly $10bn deal to buy medical technology company Masimo, two years after an activist...
  Feb 17, 2026 - $MASI
• Danaher To Acquire Masimo Corporation
  Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $
  Feb 17, 2026 - $MASI
• Danaher to Acquire Masimo in $9.9 Billion Deal
  Danaher (DHR) has agreed to acquire health technology company Masimo (MASI) in a deal worth around $
  Feb 17, 2026 - $MASI
• AI Concerns Linger, Driving Premarket Losses for US Equity Futures
  US equity futures were down ahead of Tuesday's opening bell, with futures of technology-heavy Nasdaq
  Feb 17, 2026 - $MASI
• Masimo Stock on Pace for Record Gain After Danaher Strikes Deal
  Masimo shares rocketed after biotech conglomerate Danaher struck a deal to acquire the medical-device maker for almost $10 billion. Masimo shares (MASI) surged by roughly one-third Tuesday morning to top $174.
  Feb 17, 2026 - $MASI
• Danaher Strikes $10 Billion Deal for Masimo
  The medical-device maker is expected to operate as a stand-alone company within Danaher’s Diagnostics segment.
  Feb 17, 2026 - $MASI
• This Medical-Devices Stock Is Soaring. Danaher Is Buying the Company.
  Masimo stock jumps as it agrees to be acquired by Danaher. The company is perhaps best known for its yearslong patent dispute with Apple.
  Feb 17, 2026 - $MASI